Immune checkpoint inhibitors (ICIs) have transformed cancer therapy by targeting key immune pathways such as PD-1, PD-L1, CTLA-4, and LAG-3 to enhance the immune system's ability to combat ...

Introduction Therapeutic antibodies are laboratory-engineered proteins designed to replicate the immune system's natural ability to combat dise ...

Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.

In the coming years, an unprecedented number of people will leave planet Earth—but it’s becoming increasingly clear that deep space will make us sick.

Cancer persists as one of the most daunting health issues globally, presenting significant challenges due to the heterogeneity of tumors and the complexity ...

Omeros Corporation (Nasdaq: OMER) today announced two presentations that will be featured at the 2025 Tandem Meetings – the ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

The president’s latest move takes aim at Biden’s plastic reduction efforts, calling the eco-friendly alternative "ridiculous.

"Cortisol, often referred to as the 'stress hormone' plays a vital role in our body’s response to stress," explains ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...